Iroku-Malize Tochi, Kirsch Scott
Department of Family Medicine Hofstra North Shore LIJ School of Medicine Southside Hospital, 301 East Main Street Bay Shore, NY 11706.
FP Essent. 2016 Jun;445:24-8.
Age-related macular degeneration (AMD) causes a progressive loss of photoreceptors in the macula. It is the most common cause of legal blindness in the United States, and some form of AMD is thought to affect more than 9 million individuals. Risk factors include older age, smoking, dyslipidemia, obesity, white race, female sex, and a family history of AMD. There are two types of advanced AMD: nonexudative (dry or geographic atrophy) and exudative (wet or neovascular). Both cause progressive central vision loss with intact peripheral vision. Nonexudative AMD accounts for 80% to 90% of all advanced cases, and more than 90% of patients with severe vision loss have exudative AMD. On ophthalmoscopic examination, early findings include drusen (ie, yellow deposits in the retina). Prominent choroidal vessels, subretinal edema, and/or hemorrhage are seen in wet AMD. Regular eye examinations, visual field testing, fluorescein angiography, and optical coherence tomography are used for diagnosis and to guide management. There is no specific therapy for dry AMD, but antioxidant supplementation may be helpful. Intravitreal injection of a vascular endothelial growth factor inhibitor is the treatment of choice for wet AMD. Optical aids and devices can help to maximize function for patients with AMD.
年龄相关性黄斑变性(AMD)会导致黄斑区光感受器逐渐丧失。它是美国法定失明的最常见原因,据认为某种形式的AMD会影响超过900万人。风险因素包括老年、吸烟、血脂异常、肥胖、白种人、女性以及AMD家族史。晚期AMD有两种类型:非渗出性(干性或地图状萎缩)和渗出性(湿性或新生血管性)。两者都会导致中心视力逐渐丧失而周边视力完好。非渗出性AMD占所有晚期病例的80%至90%,超过90%的严重视力丧失患者患有渗出性AMD。在眼底镜检查中,早期发现包括玻璃膜疣(即视网膜中的黄色沉积物)。湿性AMD可见明显的脉络膜血管、视网膜下水肿和/或出血。定期眼部检查、视野测试、荧光素血管造影和光学相干断层扫描用于诊断和指导治疗。干性AMD没有特异性治疗方法,但补充抗氧化剂可能有帮助。玻璃体内注射血管内皮生长因子抑制剂是湿性AMD的首选治疗方法。光学辅助器具和设备可以帮助AMD患者最大限度地发挥功能。